Peptidomimetic macrocycles
AssigneeAileron Therapeutics, Inc.
InventorsHuw M. Nash, Rosana Kapeller-Libermann, Jia-Wen Han, Tomi K. Sawyer, Justin Noehre, Noriyuki Kawahata
Life of this patent
Estimating the term…
Abstract
Disclosed are peptidomimetic macrocycles comprising a helix, such as an alpha helix, and methods of using such macrocycles for the treatment of disease such as cancer. In other aspects, the peptidomimetic macrocycle comprises an α,α-disubstituted amino acid, or may comprise a crosslinker linking the α-positions of at least two amino acids or at least one of said two amino acids may be an α,α-disubstituted amino acid. Further included is the targeting of components of the Wnt signaling pathway such as the Tcf4-/3-catenin complex.
Claims6
A peptidomimetic macrocycle comprising the amino acid sequence chosen from the group consisting of SEQ ID NOS:
- 1, 27, 43, and 44, wherein the amino acid sequence comprises a crosslinker linking the α-positions of at least two amino acids that are at least three amino acids apart within the peptidomimetic macrocycle, wherein the crosslinker is an alkylene or alkenylene crosslinker.
Dependencies are inferred from the claim text.